Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Trevi Therapeutics, Inc. Common Stock (TRVI)

Pharmaceutical Preparations

https://www.trevitherapeutics.com

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

195 CHURCH STREET, 14TH FLOOR
NEW HAVEN, CT

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/03/2019

Market Cap

194,400,876

Shares Outstanding

63,860,000

Weighted SO

63,857,622

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

1.0080

Last Div

0.0000

Range

0.97-4.0

Chg

0.0100

Avg Vol

233675

Mkt Cap

194400876

Exch

NASDAQ

Country

US

Phone

203 304 2499

DCF Diff

2.4564

DCF

0.3136

Div Yield

0.0000

P/S

1104.5504

EV Multiple

-4.2408

P/FV

4.2143

Div Yield %

0.0000

P/E

-7.1925

PEG

-0.2023

Payout

0.0000

Current Ratio

10.6826

Quick Ratio

10.6826

Cash Ratio

1.9199

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

3856.7483

CCC

-3856.7483

Gross Margin

0.1875

Op Margin

-245.3011

Pretax Margin

-220.3636

Net Margin

-220.3011

Eff Tax Rate

0.0003

ROA

-0.5253

ROE

-0.4992

ROCE

-0.6438

NI/EBT

0.9997

EBT/EBIT

0.8983

EBIT/Rev

-245.3011

Debt Ratio

0.0162

D/E

0.0180

LT Debt/Cap

0.0132

Total Debt/Cap

0.0177

Int Coverage

-43173.0000

CF/Debt

-27.4837

Equity Multi

1.1154

Rec Turnover

0.0000

Pay Turnover

0.0946

Inv Turnover

0.0000

FA Turnover

0.1250

Asset Turnover

0.0024

OCF/Share

-0.3245

FCF/Share

-0.3252

Cash/Share

0.6878

OCF/Sales

-186.2955

FCF/OCF

1.0021

CF Coverage

-27.4837

ST Coverage

-106.1100

CapEx Coverage

-482.1765

Div&CapEx Cov

-482.1765

P/BV

4.2143

P/B

4.2143

P/S

1104.5504

P/E

-7.1925

P/FCF

-5.9168

P/OCF

-8.5054

P/CF

-8.5054

PEG

-0.2023

P/S

1104.5504

EV Multiple

-4.2408

P/FV

4.2143

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation

a